Original article
Incidence and prevalence of multiple sclerosis in Spain: a systematic review
Incidencia y prevalencia de la esclerosis múltiple en España. Una revisión sistemática
F.J. García Lópeza,b,
, A. García-Merinoc, E. Alcalde-Caberob,d, J. de Pedro-Cuestaa,b
Corresponding author
a Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain
b Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
c Unidad de Neuroinmunología, Fundación para la Investigación Biomédica Hospital Universitario Puerta de Hierro Majadahonda, Universidad Autónoma de Madrid, Majadahonda, Madrid, Spain
d Agencia de Evaluación de Tecnologías Sanitarias, Instituto de Salud Carlos III, Madrid, Spain
Read
3617
Timeswas read the article
607
Total PDF
3010
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 51 | 7 | 58 |
| 2025 11 | 160 | 52 | 212 |
| 2025 10 | 112 | 27 | 139 |
| 2025 9 | 118 | 26 | 144 |
| 2025 8 | 97 | 27 | 124 |
| 2025 7 | 154 | 14 | 168 |
| 2025 6 | 89 | 21 | 110 |
| 2025 5 | 77 | 11 | 88 |
| 2025 4 | 94 | 19 | 113 |
| 2025 3 | 91 | 28 | 119 |
| 2025 2 | 92 | 32 | 124 |
| 2025 1 | 96 | 17 | 113 |
| 2024 12 | 114 | 7 | 121 |
| 2024 11 | 95 | 10 | 105 |
| 2024 10 | 97 | 15 | 112 |
| 2024 9 | 65 | 9 | 74 |
| 2024 8 | 51 | 12 | 63 |
| 2024 7 | 63 | 10 | 73 |
| 2024 6 | 53 | 10 | 63 |
| 2024 5 | 60 | 19 | 79 |
| 2024 4 | 141 | 24 | 165 |
| 2024 3 | 140 | 12 | 152 |
| 2024 2 | 141 | 27 | 168 |
| 2024 1 | 156 | 17 | 173 |
| 2023 12 | 97 | 15 | 112 |
| 2023 11 | 50 | 10 | 60 |
| 2023 10 | 69 | 16 | 85 |
| 2023 9 | 42 | 11 | 53 |
| 2023 8 | 35 | 10 | 45 |
| 2023 7 | 56 | 3 | 59 |
| 2023 6 | 77 | 6 | 83 |
| 2023 5 | 123 | 11 | 134 |
| 2023 4 | 54 | 10 | 64 |
| 2023 3 | 0 | 15 | 15 |
| 2023 2 | 0 | 22 | 22 |
| 2023 1 | 0 | 21 | 21 |
| 2022 12 | 0 | 4 | 4 |
Show all
